United States · FDA National Drug Code directory
Ryaltris
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-659_ecbea621-93b0-40ce-adce-1d304c4fdb15
- Product NDC
- 68462-659
- Form
- SPRAY, METERED
- Composition / generic term
- olopatadine hydrochloride and mometasone furoate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260113
- Source listing expiry
- 20271231
Source-listed ingredients
- OLOPATADINE HYDROCHLORIDE — 665 ug/1
- MOMETASONE FUROATE MONOHYDRATE — 25 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 CARTON in 1 BOX (68462-659-27) / 1 BOTTLE, SPRAY in 1 CARTON / 240 SPRAY, METERED in 1 BOTTLE, SPRAY · 68462-659-27
- 12 CARTON in 1 BOX (68462-659-84) / 1 BOTTLE, SPRAY in 1 CARTON / 56 SPRAY, METERED in 1 BOTTLE, SPRAY · 68462-659-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →